Pharmacotherapeutics

Advantage: Tirofiban in the Complex Puzzle of ACS Pharmacotherapeutics

09/07/2015

Cath Lab Digest talks with Thomas D. Stuckey, MD, FACC, FSCAI, Medical Director, Lebauer Foundation; Clinical Professor of Medicine, UNC School of Medicine; Cone Health Heart and Vascular Center, Greensboro, North Carolina.

Cath Lab Digest talks with Thomas D. ...

High-dose bolus tirofiban has been an excellent, cost-effective way to deal with patients who do not have optimal platelet inhibition at the time of PCI. It’s given us the flexibility to deal with that unmet need.

High-dose bolus tirofiban has...

09/07/2015

Cath Lab Digest